Joel Lilievre | Working Group for New TB Drugs

Skip to main content

Main menu

Pipeline
News
Meetings
Members
- Our Members
- Core Group
About
Join Us

Submitted by zaidtanvir on Tue, 10/18/2016 - 16:14

Role:

GSK

First Name:

Joel Lilievre

Would you like to receive updates from the WGND? Join our mailing list:

Interests

General
Pediatrics
CPTR

About Us

Part of Stop TB Partnership, we are a network of committed individuals devoted to accelerating the development of effective, affordable new therapies for TB.

Visit the Stop TB Partnership
Read about The Global Plan to End TB

Navigate

Clinical Pipeline
Discovery
Developers
Trials
Trial Sites

News
Meetings
Core Group
Members
About

Contact

The Working Group for New TB Drugs

80 Pine Street, Fl 20th
New York, NY

Follow Us

©2016 Working Group on New TB Drugs. All Rights Reserved. Terms of Reference Site by Darby Communications